engages in processing human bone and connective tissue for transplantation, as well as development, manufacture, and marketing of biologic, biomaterial, and device systems for musculoskeletal surgery.
It focuses on spinal, trauma, and total joint revision procedures.
The company provides services, and develops, markets, and sells products to the orthopaedic, neurological, oral/maxillofacial, and general surgery markets in the United States and Europe.
It offers demineralized bone grafts, structural allografts, and other allografts.
The company’s demineralized bone matrix and base tissue processing yields various freeze-dried, frozen, and demineralized allograft bone tissue forms that are used by orthopaedic, neurological, plastic, periodontal, and oral/maxillofacial surgeons.
Its products are used for spinal fusion procedures; repair and replacement of bone loss caused by trauma or certain disease states; augmentation of prosthetic implant procedures; and replacement of damaged ligaments and tendons.
The company processes and develops human bone and bone connective tissue, or allograft bone tissue forms.
It also processes, markets, and distributes bovine bone tissue products, which are utilized as bone graft substitutes by surgeons in Europe, Asia, and the Middle East.
The company was formed in 1986 and is based in Eatontown, New Jersey.
